BlackRock’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,954,565
| Closed | -$8.83M | – | 5707 |
|
|
2025
Q4 | $8.83M | Buy |
1,954,565
+938,268
| +92% | +$4.81M | ﹤0.01% | 3542 |
|
|
2025
Q3 | $5.48M | Sell |
1,016,297
-14,007
| -1% | -$75.8K | ﹤0.01% | 3741 |
|
|
2025
Q2 | $5.59M | Sell |
1,030,304
-71,778
| -7% | -$285K | ﹤0.01% | 3724 |
|
|
2025
Q1 | $3.05M | Sell |
1,102,082
-120,832
| -10% | -$420K | ﹤0.01% | 3852 |
|
|
2024
Q4 | $4.17M | Sell |
1,222,914
-141,648
| -10% | -$408K | ﹤0.01% | 3798 |
|
|
2024
Q3 | $4.01M | Sell |
1,364,562
-889,207
| -39% | -$2.93M | ﹤0.01% | 3787 |
|
|
2024
Q2 | $7.66M | Buy |
2,253,769
+278,815
| +14% | +$912K | ﹤0.01% | 3521 |
|
|
2024
Q1 | $5.98M | Buy |
1,974,954
+169,358
| +9% | +$594K | ﹤0.01% | 3603 |
|
|
2023
Q4 | $7.6M | Sell |
1,805,596
-16,934
| -0.9% | -$91.9K | ﹤0.01% | 3518 |
|
|
2023
Q3 | $12.4M | Sell |
1,822,530
-20,844
| -1% | -$184K | ﹤0.01% | 3202 |
|
|
2023
Q2 | $19.2M | Sell |
1,843,374
-129,563
| -7% | -$1.16M | ﹤0.01% | 3059 |
|
|
2023
Q1 | $13.8M | Buy |
1,972,937
+761,024
| +63% | +$6.63M | ﹤0.01% | 3157 |
|
|
2022
Q4 | $7.31M | Buy |
1,211,913
+237,530
| +24% | +$1.75M | ﹤0.01% | 3539 |
|
|
2022
Q3 | $7.68M | Sell |
974,383
-76,125
| -7% | -$888K | ﹤0.01% | 3564 |
|
|
2022
Q2 | $14.3M | Sell |
1,050,508
-865,040
| -45% | -$14.3M | ﹤0.01% | 3294 |
|
|
2022
Q1 | $37.6M | Buy |
1,915,548
+111,590
| +6% | +$2.23M | ﹤0.01% | 2748 |
|
|
2021
Q4 | $61.9M | Buy |
1,803,958
+692,463
| +62% | +$27.9M | ﹤0.01% | 2511 |
|
|
2021
Q3 | $60.7M | Buy |
1,111,495
+54,634
| +5% | +$3.29M | ﹤0.01% | 2533 |
|
|
2021
Q2 | $77.7M | Buy |
1,056,861
+1,056,745
| +910,987% | +$106M | ﹤0.01% | 2410 |
|
|
2021
Q1 | $11K | Sell |
116
-628
| -84% | -$60.9K | ﹤0.01% | 5083 |
|
|
2020
Q4 | $60K | Sell |
744
-51,722
| -99% | -$3.96M | ﹤0.01% | 4647 |
|
|
2020
Q3 | $2.44M | Buy |
+52,466
| New | +$2.93M | ﹤0.01% | 3852 |
|
BlackRock's CVAC Position: Q1 2026 in Review
BlackRock sold out of CureVac (CVAC) in Q1 2026, closing a stake of 1,954,565 shares — an estimated $8.83M sold.
BlackRock first reported a position in CVAC in Q3 2020 and held it in 22 quarters. The position peaked at $77.7M in Q2 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- BlackRock reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- BlackRock sold 1,954,565 CureVac shares in Q1 2026, an estimated $8.83M.
- BlackRock first reported a position in CureVac in Q3 2020 and held it in 22 quarters.
- BlackRock's CureVac position peaked at $77.7M in Q2 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.